WEBCAST

Neuroscience-based Nomenclature - coming of age: new developments

Content restricted!

You need to login to see this content

This Neuroscience-based Nomenclature Session by Pierre Blier, Canada, Stephen Stahl, USA, and Christoph Correll, USA, was recorded on 18 October 2022 at the 35th ECNP Congress in Vienna, Austria.

The need to update the current, 60-years-old disease-based nomenclature is clear. NbN (https://nbn2r.com/) provides an updated, pharmacologically driven, neuroscience-based nomenclature for psychotropics. It aims to help the clinician in rational prescribing, to decrease confusion for the patient (no more “antipsychotics” for depression or “antidepressants” for anxiety phenomena), to harmonize psychiatry with other fields in medicine, and to enrich the psychiatric toolbox by using pharmacological domains and mode of action to describe 60 different types of pharmacological tools that are currently available for use.  

In this session, the new developments in this widely used nomenclature (more than 100K downloads) are presented. The new NbN website (www.NbN.science) is demonstrated, which includes NbN3, NbN child and adolescent (NbNca), NbN patient and family (NbNpf), and an educational module. A new concept that has been developed in the last year –  Different Dosage Different Pharmacology (DDDP) is presented, along with clinically relevant examples (e.g., doxepin, amisulpride). The classification of dopamine blockers ("antipsychotics") in NbN, including the challenging points, is discussed. Finally,  the question of whether we can use overarching concepts such as enhancers and blockers to describe psychotropics and what are the implications is discussed. 

Views and opinions expressed in these videos are those of the presenters and do not necessarily reflect the official position of ECNP. The content of these videos should not be used in any way as the basis for treatment decisions.

Faculty

Pierre Blier

Speaker

University of Ottawa | Canada

Stephen Stahl

Speaker

University of California | United States

Christoph Correll

Speaker

Zucker School of Medicine | United States